Standout Papers

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia 2014 2026 2018 2022 403
  1. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia (2015)
    Daniel Gaudet, Veronica J. Alexander et al. New England Journal of Medicine
  2. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome (2019)
    Joseph L. Witztum, Daniel Gaudet et al. New England Journal of Medicine
  3. Targeting APOC3 in the Familial Chylomicronemia Syndrome (2014)
    Daniel Gaudet, Diane Brisson et al. New England Journal of Medicine
  4. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk (2021)
    Jean‐Claude Tardif, Ewa Karwatowska‐Prokopczuk et al. European Heart Journal
  5. Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk (2024)
    Brian A. Bergmark, Nicholas Marston et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 101 standout
Sub-graph 1 of 16

Citing Papers

Engineered commensals for targeted nose-to-brain drug delivery
2025 Standout
Diagnosis and Management of Acute Pancreatitis
2024 Standout
1 intermediate paper

Works of Veronica J. Alexander being referenced

Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study
2018
Targeting APOC3 in the Familial Chylomicronemia Syndrome
2014 Standout

Author Peers

Author Last Decade Papers Cites
Veronica J. Alexander 1577 1356 1364 43 2.7k
Weijun Jin 703 765 1131 36 2.3k
Michael B. Boffa 1102 658 2027 98 4.1k
E H Ludwig 1045 1303 1228 29 2.6k
Nicholas J. Viney 906 688 1529 21 2.3k
Narimon Honarpour 752 813 2646 49 3.7k
F. Sandhofer 572 867 978 104 2.4k
G M Fless 642 838 2101 32 3.1k
R.P. Naoumova 549 814 1523 50 2.4k
Peter Wijngaard 780 735 2790 46 4.6k
Robert F. Hoyt 639 570 1728 57 3.4k

All Works

Loading papers...

Rankless by CCL
2026